30.900
+0,00%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -32.5% | +60.5% | 2 / 3 | -19.0% | -6.39 pp | -9.12 pp | +22.4% | 0.56 | 7.83 | 90,9 | −19,0% | 41,6 | −32,5% | 7.83 | 10.16 | −23,0% |
| Pts | 0 | 12 | 8 | 0 | 0 | 0 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 30.900 (close price on 2026-10-19)EPS (TTM): 3.948
Financial charts
1.Revenue & growth
VND bn90,9Q2/26
1.Revenue & growth
VND bn90,9Q2/26
2.Profit & growth
VND bn41,6Q2/26
3.Profit mix (Penman)
VND bn212Q2/26
4.Margins & cost structure
%67.3%Q2/26
5.Returns & cash cycle
% · days17.9%Q2/26
6.Earnings quality & cash
VND bn338Q2/26
7.Asset structure
VND bn1.437Q2/26
8.Funding & debt health
VND bn · times1.437Q2/26
9.Revenue backlog
VND bn0,00Q2/26
10.Valuation
times · %7,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %831Q2/26
Adjusted EPS growth, latest quarter
-32.5%
Average adjusted EPS growth, 3 quarters
47.1%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26